CURE vs. FUTG
CURE (Direxion Daily Healthcare Bull 3x Shares) and FUTG (Leverage Shares 2X Long FUTU Daily ETF) are both Leveraged Equities funds. CURE is passively managed, while FUTG is actively managed. At a 0.02 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.75%/yr for FUTG.
Performance
CURE vs. FUTG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -18.38% return, which is significantly higher than FUTG's -75.53% return.
CURE
- 1D
- 2.17%
- 1M
- 4.39%
- YTD
- -18.38%
- 6M
- -18.70%
- 1Y
- 21.60%
- 3Y*
- -0.15%
- 5Y*
- 0.21%
- 10Y*
- 11.65%
FUTG
- 1D
- -11.10%
- 1M
- -70.24%
- YTD
- -75.53%
- 6M
- -77.00%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CURE vs. FUTG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -18.38% | 26.07% |
FUTG Leverage Shares 2X Long FUTU Daily ETF | -75.53% | -0.80% |
Correlation
The correlation between CURE and FUTG is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Oct 15, 2025 | 0.02 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. FUTG — Risk / Return Rank
CURE
FUTG
CURE vs. FUTG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Leverage Shares 2X Long FUTU Daily ETF (FUTG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE | FUTG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.12 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 0.70 | — | — |
| Martin ratioReturn relative to average drawdown | 1.61 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE | FUTG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.50 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.00 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | -0.66 | +1.12 |
Drawdowns
CURE vs. FUTG - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum FUTG drawdown of -86.19%. Use the drawdown chart below to compare losses from any high point for CURE and FUTG.
Loading charts...
Drawdown Indicators
| CURE | FUTG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -86.19% | +17.00% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | — | — |
Current DrawdownCurrent decline from peak | -35.21% | -84.29% | +49.08% |
Average DrawdownAverage peak-to-trough decline | -18.15% | -40.35% | +22.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.43% | — | — |
Volatility
CURE vs. FUTG - Volatility Comparison
Loading charts...
Volatility by Period
| CURE | FUTG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.99% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 29.83% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 43.19% | 136.01% | -92.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.69% | 136.01% | -92.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.51% | 136.01% | -86.50% |
CURE vs. FUTG - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than FUTG's 0.75% expense ratio.
Dividends
CURE vs. FUTG - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.31%, while FUTG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.31% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
FUTG Leverage Shares 2X Long FUTU Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CURE and FUTG have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, FUTG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
FUTG is cheaper with a 0.75% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.31%, compared with 0.00% for FUTG.
They also come from different issuers: Direxion and Leverage Shares. Their fees differ too: 1.08% for CURE and 0.75% for FUTG.
Find the right allocation for CURE and FUTG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer